By Khushi Mandowara and Leroy Leo (Reuters) -Humana Inc raised its annual adjusted profit forecast on Wednesday after lower medical costs in the firm’s government-backed health insurance busines[...]
Read more
Health
Factbox-Microsoft-Activision deal joins mega mergers facing regulatory heat
(Reuters) – Microsoft’s $69 billion acquisition of “Call of Duty” maker Activision Blizzard has been blocked by Britain over concerns it would hinder competition in cloud gamin[...]
Read more
China’s Ping An Insurance posts 48.9% rise in Q1 profit
BEIJING (Reuters) – Ping An Insurance (Group) Co of China Ltd saw a 48.9% rise in first-quarter net profit as its investment income improved, China’s largest insurer by market value report[...]
Read more
Roche Q1 sales decline tempered by swift uptake of new eye drug
By Ludwig Burger (Reuters) -Switzerland’s Roche said first-quarter sales dropped 7% on falling demand for its COVID-19 therapies and tests, less steep than analysts had expected thanks to strong[...]
Read more
GSK stays strong as healthy sales beat expectations
By Natalie Grover and Maggie Fick LONDON (Reuters) -GSK began 2023 with a quarterly performance that beat analyst expectations and extended a series of positive results thanks to strong sales of its v[...]
Read more
Biogen trims pipeline programs to cut costs, focus on Alzheimer’s drug launch
By Sriparna Roy and Bhanvi Satija (Reuters) -Biogen Inc said on Tuesday it will pause or discontinue at least four studies of experimental drugs to focus on more potentially lucrative options includin[...]
Read more
Novartis, helped by cost cuts, raises full-year outlook
By Ludwig Burger FRANKFURT (Reuters) -Novartis on Tuesday raised its full-year earnings outlook following cost cuts, a breast cancer drug trial success and progress in boosting output of a radiotherap[...]
Read more
J&J aims for up to $43 billion valuation for consumer health unit Kenvue
By Akash Sriram and Manya Saini (Reuters) -Johnson & Johnson said on Monday it was seeking a valuation of up to $42.95 billion in the initial public offering of its consumer health unit, Kenvue, a[...]
Read more
Cancer victims urge US judge to dismiss J&J talc unit second bankruptcy
By Dietrich Knauth (Reuters) -Cancer victims on Monday urged a U.S. judge to dismiss a Johnson & Johnson subsidiary’s second bankruptcy filing, saying the company is abusing the bankruptcy s[...]
Read more